Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Enovis Corporation Common Stock (NY:ENOV)

17.73 -0.47 (-2.58%)
Delayed Quote Updated: 1:35 PM EDT, Oct 7, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Enovis Corporation Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
3 Small-Cap Stocks We Approach with Caution
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th... 
Via StockStory
News headline image
1 Oversold Stock Ready to Bounce Back and 2 That Underwhelm
Rock-bottom prices don’t always mean rock-bottom businesses. The stocks we’re examining today have all touched their 52-week lows, creating a classic investo... 
Via StockStory
News headline image
2 Russell 2000 Stocks on Our Watchlist and 1 We Brush Off
Small-cap stocks in the Russell 2000 (^RUT) can be a goldmine for investors looking beyond the usual large-cap names. But with less stability and fewer resou... 
Via StockStory
News headline image
3 Reasons ENOV is Risky and 1 Stock to Buy Instead
Shareholders of Enovis would probably like to forget the past six months even happened. The stock dropped 20.4% and now trades at $18.67. This may have inves... 
Via StockStory
Topics Artificial Intelligence
Enovis Corp. (NYSE:ENOV) Beats Q1 Estimates, Reaffirms Guidance ↗
Via Chartmill
News headline image
Insider at Medical Device Maker Buys More Than 7,500 Shares ↗
Engert's $150,000 purchase represents a 14% increase to his direct holdings, signaling confidence despite stock's -37% one-year decline. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Q2 Earnings Highlights: Enovis (NYSE:ENOV) Vs The Rest Of The Medical Devices & Supplies - Specialty Stocks
As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the medical devices & supplies - specialty industry, including En... 
Via StockStory
News headline image
Enovis Targets Robotic Surgery Expansion With €155M eCential Robotics Deal ↗
Enovis (NYSE:ENOV) said it has entered a binding offer to acquire eCential Robotics, a developer of surgical robotics technology, in a move the orthopedic company said will expand its... 
Via MarketBeat
News headline image
3 Stocks Under $50 We Approach with Caution
The $10-50 price range often includes mid-sized businesses with proven track records and plenty of growth runway ahead. They also usually carry less risk tha... 
Via StockStory
News headline image
Enovis Q2 Earnings Call Highlights ↗
Enovis (NYSE:ENOV) reported second-quarter 2026 sales of $583 million, up 3% on a reported basis and 5% organically, as growth in its Reconstruction business offset a slower but still expanding... 
Via MarketBeat
Topics Earnings Economy
News headline image
Why Enovis (ENOV) Shares Are Sliding Today
What Happened? Shares of medical technology company Enovis Corporation (NYSE:ENOV) fell 12.8% in the afternoon session after the company reported second-quar... 
Via StockStory
News headline image
Enovis (NYSE:ENOV) Posts Q2 CY2026 Sales In Line With Estimates
Medical technology company Enovis Corporation (NYSE:ENOV) met Wall Street’s revenue expectations in Q2 CY2026, with sales up 3.2% year on year to $582.8 mill... 
Via StockStory
News headline image
Enovis (ENOV) Reports Q2: Everything You Need To Know Ahead Of Earnings
Medical technology company Enovis Corporation (NYSE:ENOV) will be reporting earnings this Thursday morning. Here’s what to expect. Enovis beat analysts’ reve... 
Via StockStory
Topics Artificial Intelligence
News headline image
1 Unprofitable Stock to Own for Decades and 2 Facing Challenges
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, th... 
Via StockStory
News headline image
3 of Wall Street’s Favorite Stocks We Approach with Caution
Wall Street has set ambitious price targets for the stocks in this article. While this suggests attractive upside potential, it’s important to remain skeptic... 
Via StockStory
News headline image
STAAR Surgical, Globus Medical, Integer Holdings, and Enovis Stocks Trade Down, What You Need To Know
What Happened? A number of stocks fell in the afternoon session after a key industry player warned that changes to some insurance plans could slow U.S. proce... 
Via StockStory
News headline image
Stocks making big moves this week: HCA Healthcare, UnitedHealth, CrowdStrike, RXO, and Enovis
Check out the companies making headlines this week: HCA Healthcare (NYSE:HCA): Hospital operator HCA Healthcare (NYSE:HCA) fell by 6.7% on Tuesday after the ... 
Via StockStory
News headline image
Enovis (ENOV) Stock Trades Up, Here Is Why
What Happened? Shares of medical technology company Enovis Corporation (NYSE:ENOV) jumped 3.6% in the afternoon session after the company announced the U.S. ... 
Via StockStory
News headline image
Why Enovis (ENOV) Stock Is Trading Up Today
What Happened? Shares of medical technology company Enovis Corporation (NYSE:ENOV) jumped 15% in the afternoon session after the Centers for Medicare & Medic... 
Via StockStory
News headline image
4 Top Growth Stocks Worth Buying Under $100 Today ↗
These four under-the-radar stocks are built to benefit from powerful secular trends that could reward patient, long-term investors. 
Via The Motley Fool
News headline image
1 Oversold Stock Primed to Rebound and 2 We Find Risky
The past year hasn’t been kind to the stocks featured in this article. Each has tumbled to its lowest point in 12 months, leaving investors to decide whether... 
Via StockStory
Topics Bonds
News headline image
Spotting Winners: Enovis (NYSE:ENOV) And Medical Devices & Supplies - Specialty Stocks In Q1
Looking back on medical devices & supplies - specialty stocks’ Q1 earnings, we examine this quarter’s best and worst performers, including Enovis (NYSE:ENOV)... 
Via StockStory
News headline image
3 Reasons ENOV is Risky and 1 Stock to Buy Instead
Over the last six months, Enovis’s shares have sunk to $22.66, producing a disappointing 16.1% loss - a stark contrast to the S&P 500’s 10% gain. This might ... 
Via StockStory
Topics Artificial Intelligence Stocks
News headline image
3 Healthcare Stocks That Fall Short
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. But speed bumps such as inventory destocking... 
Via StockStory
News headline image
ront Street Bought 384K More Shares of Enovis in Q1. Is ENOV a Buy Now? ↗
Enovis develops orthopedic and rehabilitation devices for healthcare providers, serving a broad spectrum of musculoskeletal patient needs. 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
1 Small-Cap Stock to Target This Week and 2 We Turn Down
Investors looking for hidden gems should keep an eye on small-cap stocks because they’re frequently overlooked by Wall Street. Many opportunities exist in th... 
Via StockStory
News headline image
3 Russell 2000 Stocks We’re Skeptical Of
The Russell 2000 (^RUT) is packed with potential breakout stocks, thanks to its focus on smaller companies with high growth potential. However, smaller size ... 
Via StockStory
Topics Artificial Intelligence
News headline image
Enovis Q1 Earnings Call Highlights ↗
Enovis (NYSE:ENOV) reported a solid start to 2026, with management pointing to share gains in its reconstructive surgery business, stable growth in prevention and recovery, and continued investment in... 
Via MarketBeat
Topics Earnings
News headline image
Enovis (ENOV) Q1 2026 Earnings Transcript ↗
Enovis (ENOV) Q1 2026 Earnings Transcript 
Via The Motley Fool
Topics Regulatory Compliance World Trade
News headline image
Why Is Enovis (ENOV) Stock Rocketing Higher Today
What Happened? Shares of medical technology company Enovis Corporation (NYSE:ENOV) jumped 7.6% in the afternoon session after the company reported better-tha... 
Via StockStory
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.